Tokyo, June 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061869) titled 'A cross-sectional study on the continuous consumption of royal jelly and/or propolis and health status' on June 11.
Study Type:
Observational
Primary Sponsor:
Institute - Yamada Bee Company, Inc.
Condition:
Condition - Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the association between the long-term consumption of royal jelly and/or propolis and health status, with a specific focus on frailty and pre-frailty, as well as quality of life.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Men and women aged 40 years and older.
2. Individuals who consume royal jelly products, propolis products, or both, manufactured by Yamada Bee Company, Inc.
Key exclusion criteria - none
Target Size - 7346
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 18 Day
Date of IRB - 2026 Year 05 Month 18 Day
Anticipated trial start date - 2026 Year 06 Month 15 Day
Last follow-up date - 2026 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070763
Disclaimer: Curated by HT Syndication.
